Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 8/20 | 0.58 |
| ▸ | MAPT | P10636 | 7/20 | 0.58 |
| ▸ | RAB9A | P51151 | 6/20 | 0.58 |
| ▸ | LMNA | P02545 | 6/20 | 0.58 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.58 |
| ▸ | GAA | P10253 | 5/20 | 0.58 |
| ▸ | TDP1 | Q9NUW8 | 5/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.58 |
| ▸ | POLB | P06746 | 2/20 | 0.58 |
| ▸ | PAX8 | Q06710 | 2/20 | 0.56 |
| ▸ | NPC1 | O15118 | 4/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.55 |
| ▸ | MEN1 | O00255 | 1/20 | 0.55 |
| ▸ | NOX1 | Q9Y5S8 | 1/20 | 0.55 |
| ▸ | MAOA | P21397 | 1/20 | 0.55 |
| ▸ | HTT | P42858 | 6/20 | 0.54 |
| ▸ | NPSR1 | Q6W5P4 | 4/20 | 0.54 |
| ▸ | PKM | P14618 | 4/20 | 0.54 |
| ▸ | CA12 | O43570 | 1/20 | 0.53 |
| ▸ | CA1 | P00915 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6711432 | 1.00 | KDM4E (0.58) | KDM4EMAPTRAB9ALMNASMN1; SMN2 | |
| SCHEMBL6493566 | 0.86 | RAB9A (0.59) | KDM4EMAPTRAB9ALMNASMN1; SMN2 | |
| SCHEMBL4807384 | 0.86 | KDM4E (0.56) | KDM4EMAPTRAB9ALMNASMN1; SMN2 | |
| SCHEMBL4807377 | 0.86 | KDM4E (0.56) | KDM4EMAPTRAB9ALMNASMN1; SMN2 | |
| SCHEMBL6501236 | 0.86 | RAB9A (0.60) | KDM4EMAPTRAB9ALMNASMN1; SMN2 | |
| SCHEMBL4811734 | 0.85 | KDM4E (0.57) | KDM4EMAPTRAB9ALMNASMN1; SMN2 | |
| SCHEMBL4878568 | 0.85 | KDM4E (0.57) | KDM4EMAPTRAB9ALMNASMN1; SMN2 | |
| SCHEMBL12858541 | 0.85 | RAB9A (0.69) | KDM4EMAPTRAB9ALMNASMN1; SMN2 | |
| SCHEMBL28170008 | 0.83 | PAX8 (0.58) | KDM4EMAPTRAB9ALMNASMN1; SMN2 | |
| SCHEMBL6504390 | 0.82 | CTH (0.57) | KDM4EMAPTRAB9ALMNASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 44 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040053977-A1 | Medicinal uses of hydrazones | ALMSTEAD JI-IN KIM (US) | 2004-03-18 | — | — | US | claimed |
| US-6660737-B2 | Antihypoxic agents | THE PROCTER & GAMBLE COMPANY | 2003-12-09 | — | — | US | claimed |
| US-20030092716-A1 | Medicinal uses of hydrazones | THE PROCTER & GAMBLE COMPANY | 2003-05-15 | — | — | US | claimed |
| US-7833331-B2 | Non-toxic corrosion-protection pigments based on cobalt | UNIVERSITY OF DAYTON (US) | 2010-11-16 | — | — | US | disclosed |
| US-7789958-B2 | Non-toxic corrosion-protection pigments based on manganese | UNIVERSITY OF DAYTON (US) | 2010-09-07 | — | — | US | disclosed |
| US-20090163628-A1 | NON-TOXIC CORROSION-PROTECTION PIGMENTS BASED ON COBALT | STURGILL JEFFREY ALLEN | 2009-06-25 | — | — | US | disclosed |
| US-7537663-B2 | Corrosion-inhibiting coating | UNIVERSITY OF DAYTON (US) | 2009-05-26 | — | — | US | disclosed |
| US-7422793-B2 | Non-toxic corrosion-protection rinses and seals based on rare earth elements | UNIVERSITY OF DAYTON (US) | 2008-09-09 | — | — | US | disclosed |
| US-7407711-B2 | Non-toxic corrosion-protection conversion coats based on rare earth elements | UNIVERSITY OF DAYTON (US) | 2008-08-05 | — | — | US | disclosed |
| US-7294211-B2 | Non-toxic corrosion-protection conversion coats based on cobalt | UNIVERSITY OF DAYTON (US) | 2007-11-13 | — | — | US | disclosed |
| US-7291217-B2 | Non-toxic corrosion-protection pigments based on rare earth elements | UNIVERSITY OF DAYTON (US) | 2007-11-06 | — | — | US | disclosed |
| US-4322536-A | Process for producing pyridinaldehydes | CIBA-GEIGY CORPORATION (US) | 1982-03-30 | — | — | US | disclosed |
| US-4322536-A | Process for producing pyridinaldehydes | CIBA-GEIGY CORPORATION (US) | 1982-03-30 | — | — | US | disclosed |
| EP-0023652-A1 | Process for the preparation of cationic dyestuffs | BAYER AG (DE) | 1981-02-11 | — | — | EP | disclosed |
| US-4237275-A | Process for producing hydrazone derivatives of pyridinaldehydes | CIBA-GEIGY CORPORATION (US) | 1980-12-02 | — | — | US | disclosed |
| US-4237275-A | Process for producing hydrazone derivatives of pyridinaldehydes | CIBA-GEIGY CORPORATION (US) | 1980-12-02 | — | — | US | disclosed |
| US-4212868-A | Certain fungicidal pyridinecarbaldehyde phenylhydrazones | SHELL OIL COMPANY (US) | 1980-07-15 | — | — | US | disclosed |
| US-4212868-A | Certain fungicidal pyridinecarbaldehyde phenylhydrazones | SHELL OIL COMPANY (US) | 1980-07-15 | — | — | US | disclosed |
| EP-0008323-A1 | Process for the preparation of pyridine aldehydes and their derivatives, and compounds made by this process | CIBA-GEIGY AG (CH) | 1980-03-05 | — | — | EP | disclosed |
| EP-0008323-A1 | Process for the preparation of pyridine aldehydes and their derivatives, and compounds made by this process | CIBA-GEIGY AG (CH) | 1980-03-05 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040053977-A1 | Medicinal uses of hydrazones | PGF, VEGFA, TEK | KDM4E 4483/4885MAPT 4168/4885RAB9A 3979/4885 |
| US-20030092716-A1 | Medicinal uses of hydrazones | EPOR, VEGFA, HIF1A | KDM4E 4428/4885MAPT 4120/4885RAB9A 3507/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.